CD44 and leukemia: CD44 mediates cell–cell or cell–extracellular matrix interactions, and its blockade with a monoclonal antibody had been shown to revert differentiation block of myeloblasts, inhibit their proliferation (Charrad et al, 2002), and block leukemia stem cells (LSC) from trafficking to their supportive niche (Jin et al, 2006).